Daiwa Securities Group’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1K | Hold |
650
| – | – | ﹤0.01% | 1258 |
|
2025
Q1 | $1K | Sell |
650
-38,500
| -98% | -$59.2K | ﹤0.01% | 1223 |
|
2024
Q4 | $85K | Buy |
39,150
+650
| +2% | +$1.41K | ﹤0.01% | 1006 |
|
2024
Q3 | $63K | Hold |
38,500
| – | – | ﹤0.01% | 1044 |
|
2024
Q2 | $85K | Hold |
38,500
| – | – | ﹤0.01% | 1034 |
|
2024
Q1 | $103K | Hold |
38,500
| – | – | ﹤0.01% | 1043 |
|
2023
Q4 | $115K | Sell |
38,500
-235
| -0.6% | -$702 | ﹤0.01% | 994 |
|
2023
Q3 | $37K | Hold |
38,735
| – | – | ﹤0.01% | 1073 |
|
2023
Q2 | $53K | Hold |
38,735
| – | – | ﹤0.01% | 1067 |
|
2023
Q1 | $61K | Hold |
38,735
| – | – | ﹤0.01% | 1027 |
|
2022
Q4 | $240K | Sell |
38,735
-25,700
| -40% | -$159K | ﹤0.01% | 916 |
|
2022
Q3 | $432K | Hold |
64,435
| – | – | ﹤0.01% | 829 |
|
2022
Q2 | $409K | Sell |
64,435
-25,617
| -28% | -$163K | ﹤0.01% | 863 |
|
2022
Q1 | $417K | Buy |
90,052
+20,000
| +29% | +$92.6K | ﹤0.01% | 884 |
|
2021
Q4 | $350K | Buy |
70,052
+70,000
| +134,615% | +$350K | ﹤0.01% | 914 |
|
2021
Q3 | $1K | Hold |
52
| – | – | ﹤0.01% | 1263 |
|
2021
Q2 | $1K | Hold |
52
| – | – | ﹤0.01% | 1184 |
|
2021
Q1 | $1K | Hold |
52
| – | – | ﹤0.01% | 1193 |
|
2020
Q4 | $1K | Sell |
52
-102
| -66% | -$1.96K | ﹤0.01% | 1171 |
|
2020
Q3 | $6K | Hold |
154
| – | – | ﹤0.01% | 1063 |
|
2020
Q2 | $5K | Hold |
154
| – | – | ﹤0.01% | 1091 |
|
2020
Q1 | $5K | Hold |
154
| – | – | ﹤0.01% | 1090 |
|
2019
Q4 | $9K | Sell |
154
-17
| -10% | -$994 | ﹤0.01% | 1064 |
|
2019
Q3 | $6K | Hold |
171
| – | – | ﹤0.01% | 1052 |
|
2019
Q2 | $8K | Hold |
171
| – | – | ﹤0.01% | 1048 |
|
2019
Q1 | $7K | Buy |
171
+26
| +18% | +$1.06K | ﹤0.01% | 1041 |
|
2018
Q4 | $7K | Hold |
145
| – | – | ﹤0.01% | 1016 |
|
2018
Q3 | $6K | Hold |
145
| – | – | ﹤0.01% | 1056 |
|
2018
Q2 | $6K | Hold |
145
| – | – | ﹤0.01% | 1071 |
|
2018
Q1 | $10K | Buy |
+145
| New | +$10K | ﹤0.01% | 1018 |
|